Choline Fenofibrate

Records for this ingredient, by country (identity only).

ATC C10AB11 · 3 markets · 7 records

Choline Fenofibrate 3 markets · 7 records Forms

Filters

MarketUS 4 SG 2

Strength

US 4 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

135 mgcapsule · delayed-releaseManufacturer: Lupin Pharmaceuticals, Inc. ×2+1Manufacturer: Macleods Pharmaceuticals Li… also in SG
45 mgcapsule · delayed-releaseManufacturer: Lupin Pharmaceuticals, Inc. ×2+1Manufacturer: Macleods Pharmaceuticals Li… also in SG

SG 2 records · 2 shown of 2 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

135 mgcapsule · delayed-releaseTrilipix Modified Release Capsules 135mg also in US
45 mgcapsule · delayed-releaseTrilipix Modified Release Capsules 135mg also in US

Side-by-side table

Strength / form / release	US	SG
135 mg capsule · delayed-release	Manufacturer: Lupin Pharmaceuticals, Inc. ×2 Manufacturer: Macleods Pharmaceuticals Li… ×2	Trilipix Modified Release Capsules 135mg
45 mg capsule · delayed-release	Manufacturer: Lupin Pharmaceuticals, Inc. ×2 Manufacturer: Macleods Pharmaceuticals Li… ×2	Trilipix Modified Release Capsules 135mg

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.